Abstract
Objective: To evaluate the relationship between hypoxic ischemic injury (HII) and glymphatic function in neonates using two imaging biomarkers; basal ganglia perivascular space (BGPVS) volume and diffusion tensor imaging along the perivascular space (DTI ALPS) and to explore their interconnection. Methods: This retrospective single institution study collected neonatal brain MRIs from July 2020 to July 2022. BGPVS volume and fraction were automatically extracted from 3D T2-weigthed images processing. DTI ALPS indices were derived from DTI maps. Comparisons of BGPVS parameters and DTI ALPS indices were performed between neonates with and without HII. Logistic regression adjusted for age, sex, birth weight, and delivery mode. Correlations between BGPVS parameters and DTI ALPS indices were also evaluated. Results: The study included 97 neonates without HII (median gestational age 252 days; 46 males) and 30 with HII (252 days; 16 males). Neonates with HII had smaller BG-PVS volumes (19 vs. 33 mm^3, p = 0.001) and fractions (0.29% vs. 0.54%, p = 0.003) compared to neonates without HII. Logistic regression revealed a negative association between BGPVS volume (OR: 0.96, 95% CI: 0.93 to 0.99) and fraction (OR: 0.15, 95% CI: 0.03 to 0.79) with HII. DTI ALPS indices showed no evidence of differences between the neonates with and without HII (p = 0.54) or association with HII (p = 0.41). BGPVS parameters and DTI-ALPS indices showed no evidence of correlation (coefficient = -0.28 to -0.08, ps > 0.05). Conclusion: Neonates with HII demonstrated smaller BGPVS volume and fraction compared to those without injury, indicating potential alterations in glymphatic function among affected newborns.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2021R1A2C1007831) and the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2023S1A5A2A21085832)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board review was obtained from the Ethics Committee of Eunpyeong St. Marys' Hospital (PC24RISI0104)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
